1,448 results on '"Peters, Godefridus J."'
Search Results
2. Management of neurological symptoms in Lesch-Nyhan disease: A systematic review
3. Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growth
4. Cancer: A Complex Problem Requiring Interdisciplinary Research
5. Pegylated nanoliposomal cisplatin ameliorates chemotherapy-induced peripheral neuropathy
6. Combined inhibition of pyruvate dehydrogenase kinase 1 and lactate dehydrogenase a induces metabolic and signaling reprogramming and enhances lung adenocarcinoma cell killing
7. Role of exosomes in transferring chemoresistance through modulation of cancer glycolytic cell metabolism
8. Extracellular vesicles: Emerging mediators of cell communication in gastrointestinal cancers exhibiting metabolic abnormalities
9. Correction to: Cancer: A Complex Problem Requiring Interdisciplinary Research
10. Newly synthesized acridone derivatives targeting lung cancer: A toxicity and xenograft model study
11. Evaluation of N4-hydroxycytidine incorporation into nucleic acids of SARS-CoV-2-infected host cells by direct measurement with liquid chromatography-mass spectrometry
12. Effects of nucleoside analogues, lipophilic prodrugs and elaidic acids on core signaling pathways in cancer cells
13. Mechanisms underlying reversed TRAIL sensitivity in acquired bortezomib-resistant non-small cell lung cancer cells
14. G-Protein Signaling Modulator 2 as a Potential Biomarker in Colorectal Cancer: Integrative Analysis Using Genetic Profiling and Pan-Cancer Studies
15. Nucleo(s)tide metabolism as basis for drug development; the Anne Simmonds award lecture.
16. Exploring Splicing Modulation as an Innovative Approach to Combat Pancreatic Cancer: SF3B1 Emerges as a Prognostic Indicator and Therapeutic Target.
17. Correction to: Cancer: A Complex Problem Requiring Interdisciplinary Research
18. Pharmacological mechanisms underlying the interaction of the nucleoside analogue gemcitabine with the c-MET inhibitor tivantinib in pancreatic cancer
19. Academia Oncology: a forum for interdisciplinary cancer research
20. Hype or hope – Can combination therapies with third-generation EGFR-TKIs help overcome acquired resistance and improve outcomes in EGFR-mutant advanced/metastatic NSCLC?
21. GSK3β as a novel promising target to overcome chemoresistance in pancreatic cancer
22. Combination of HGF/MET-targeting agents and other therapeutic strategies in cancer
23. The prognostic impact of circulating miRNAs in patients with advanced esophagogastric cancer during palliative chemotherapy
24. A bug in the resistance to EGFR inhibitors: is there a role for Mycoplasma and cytidine deaminase in reducing the activity of osimertinib in lung cancer patients?
25. Exploring the role of oxidative stress and the effect of N‐acetylcysteine in thiopurine‐induced liver injury in inflammatory bowel disease: A randomized crossover pilot study.
26. Imidazo[2,1-b] [1,3,4]thiadiazoles with antiproliferative activity against primary and gemcitabine-resistant pancreatic cancer cells
27. Looking for the unexpected in purine and pyrimidine metabolism
28. Impact of hypoxia on chemoresistance of mesothelioma mediated by the proton-coupled folate transporter, and preclinical activity of new anti-LDH-A compounds
29. NUC-1031 in biliary tract cancer: from bench to bedside and back?
30. Thiopurines with low-dose allopurinol (ThiLDA)—a prospective clinical one-way crossover trial
31. Corrigendum to “Discovery of anticancer agents with c-Met inhibitory potential by virtual and experimental screening of a chemical library” [Europ. J. Pharmacol. (2023) 938: 175395]
32. Ex vivo resistance in childhood acute lymphoblastic leukemia: Correlations between BCRP, MRP1, MRP4 and MRP5 ABC transporter expression and intracellular methotrexate polyglutamate accumulation
33. The Prognostic Value of ASPHD1 and ZBTB12 in Colorectal Cancer: A Machine Learning-Based Integrated Bioinformatics Approach
34. Contributors
35. Drug resistance in colorectal cancer: General aspects
36. Re-emerging Antimetabolites with Novel Mechanism of Action with Respect to Epigenetic Regulation: Basic Aspects
37. Elucidation of chemosensitization effect of acridones in cancer cell lines: Combined pharmacophore modeling, 3D QSAR, and molecular dynamics studies
38. Double Trouble: A Case Series on Concomitant Genetic Aberrations in NSCLC
39. Proteasome inhibition and mechanism of resistance to a synthetic, library-based hexapeptide
40. Acridone-pyrimidine hybrids- design, synthesis, cytotoxicity studies in resistant and sensitive cancer cells and molecular docking studies
41. Target Therapy in Malignant Pleural Mesothelioma: Hope or Mirage?
42. Metabolic Effects of New Glucose Transporter (GLUT-1) and Lactate Dehydrogenase-A (LDH-A) Inhibitors against Chemoresistant Malignant Mesothelioma
43. Data from Molecular Mechanisms Involved in the Synergistic Interaction of the EZH2 Inhibitor 3-Deazaneplanocin A with Gemcitabine in Pancreatic Cancer Cells
44. Supplementary Figure 2 from Molecular Mechanisms Involved in the Synergistic Interaction of the EZH2 Inhibitor 3-Deazaneplanocin A with Gemcitabine in Pancreatic Cancer Cells
45. Supplementary Figure 1 from Molecular Mechanisms Involved in the Synergistic Interaction of the EZH2 Inhibitor 3-Deazaneplanocin A with Gemcitabine in Pancreatic Cancer Cells
46. Supplementary Figure Legend from Molecular Mechanisms Involved in the Synergistic Interaction of the EZH2 Inhibitor 3-Deazaneplanocin A with Gemcitabine in Pancreatic Cancer Cells
47. The Influence of Mitochondrial Energy and 1C Metabolism on the Efficacy of Anticancer Drugs: Exploring Potential Mechanisms of Resistance
48. A mechanopharmacology approach to overcome chemoresistance in pancreatic cancer
49. Hollow Fiber Assay
50. Pancreatic cancer resistance conferred by stellate cells: looking for new preclinical models
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.